MMedication Read More Nasal Spray Could Protect Against Range of Respiratory BugsFebruary 22, 2026 Scientists are testing a nasal spray that aims to put lungs on alert against just about any…
HHealth Read More Early hydrocortisone treatment improves survival for extremely premature babiesFebruary 20, 2026 Early hydrocortisone treatment of extremely premature babies increases their chances of survival without lung disease, according to a…
HHealth Read More AI tool could help identify life-threatening transplant complicationsFebruary 16, 2026 A powerful artificial intelligence (AI) tool could give clinicians a head start in identifying life-threatening complications after stem…
HHealth Read More RNA micelles enable targeted chemotherapy without immune toxicityFebruary 8, 2026 A new study in mice hints at the potential to use tiny particles made with RNA molecules to…
HHealth Read More Artificial lung keeps patient alive after lung removalFebruary 5, 2026 By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed…
HHealth Read More Study finds no safety or efficacy gap between paracetamol and ibuprofen for neonatal PDAJanuary 22, 2026 A small but rigorous randomized trial suggests paracetamol may be a feasible alternative to ibuprofen for late PDA…
HHealth Read More Pneumonia in winters: Early warning signs parents should watch out for, 4 tips to protect your child’s lungs |December 21, 2025 Winter Is Peak Season for Childhood Pneumonia: These Symptoms Should Send Parents to the Doctor Pneumonia is one…
HHealth Read More Flu wave’s hidden cost on people with cystic fibrosisDecember 18, 2025 People with cystic fibrosis (CF) are uniquely vulnerable to the flu wave currently ripping through the UK, a…
HHealth Read More Genetic differences in surfactant proteins influence retinopathy of prematurity riskDecember 13, 2025 A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously…
HHealth Read More Enterprise Therapeutics publishes results of Phase 1 study of ETD001, a novel inhaled ENaC blocker for treatment of Cystic Fibrosis, in The Journal of Cystic FibrosisDecember 9, 2025 Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve…
HHealth Read More Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancerDecember 5, 2025 Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows…
HHealth Read More Long-term exposure to polluted air weakens the health benefits of exerciseNovember 29, 2025 Long-term exposure to toxic air can substantially weaken the health benefits of regular exercise, suggests a new study…